SCHEDULE: Venrock Affiliates Disclose 5.2% Stake in Savara Inc.

A group of Venrock-affiliated entities and individuals have disclosed a collective beneficial ownership of 5.2% of Savara Inc.'s common stock, totaling 9,021,507 shares.

Summary

• A Schedule 13G filing indicates that a group of seven reporting persons, including Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Koh, collectively beneficially own 9,021,507 shares of Savara Inc. common stock.
• This aggregate ownership represents 5.2% of Savara Inc.'s outstanding common stock.
• The percentage is calculated based on 172,836,922 shares of common stock outstanding as of May 13, 2025, as reported in Savara Inc.'s Quarterly Report on Form 10-Q.
• The reporting persons share both voting and dispositive power over all 9,021,507 shares.
• The filing states that the securities were not acquired or held for the purpose of changing or influencing the control of Savara Inc., except for activities solely related to a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or prospects. It is a neutral regulatory filing.

Risks

• The reporting persons explicitly state that the securities were not acquired or held for the purpose of changing or influencing the control of Savara Inc., which mitigates the risk of an activist investor seeking immediate control changes, though it does allow for activities solely in connection with a nomination under Rule 14a-11.

Future Outlook

NA

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing indicates a significant investment by a healthcare-focused capital group (Venrock Healthcare Capital Partners) in Savara Inc., suggesting continued institutional interest in the healthcare or biotechnology sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The disclosure of a significant 5.2% stake by a group of institutional investors provides transparency regarding the ownership structure and may be viewed as a notable institutional presence.

Next Steps

• The reporting persons are required to file any necessary amendments to this Schedule 13G if there are material changes to their beneficial ownership.
• Bong Koh and Nimish Shah's Power of Attorney remains in effect until they are no longer required to file forms, revoke it in writing, or their attorney-in-fact is no longer employed by Venrock.

Key Dates

Keywords

Savara Inc., Venrock Healthcare Capital Partners, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Equity Stake, Biotechnology, Pharmaceuticals